<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 02 Jun 2026 16:37:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  144        ILLUMINA, INC.                         Filed by: ARNOLD FRANCES</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+ARNOLD+FRANCES/26592422.html</link>
   <description>si-local-file:///var/storage/secattach/20260602/26592422.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+ARNOLD+FRANCES/26592422.html</guid>
   <pubDate>Tue, 02 Jun 2026 16:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>Form  144        ILLUMINA, INC.                         Filed by: ARNOLD FRANCES</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+ARNOLD+FRANCES/26592422.html</link>
   <description>si-local-file:///var/storage/secattach/20260602/26592422.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+ARNOLD+FRANCES/26592422.html</guid>
   <pubDate>Tue, 02 Jun 2026 16:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>Form  144        ILLUMINA, INC.                         Filed by: Leckman Patricia</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Leckman+Patricia/26592022.html</link>
   <description>si-local-file:///var/storage/secattach/20260602/26592022.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Leckman+Patricia/26592022.html</guid>
   <pubDate>Tue, 02 Jun 2026 16:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>Form  144        ILLUMINA, INC.                         Filed by: Leckman Patricia</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Leckman+Patricia/26592022.html</link>
   <description>si-local-file:///var/storage/secattach/20260602/26592022.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Leckman+Patricia/26592022.html</guid>
   <pubDate>Tue, 02 Jun 2026 16:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>Form  4          ILLUMINA, INC.            For: May 28  Filed by: Meister Keith A.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+28++Filed+by%3A+Meister+Keith+A./26585404.html</link>
   <description>si-local-file:///var/storage/secattach/20260601/26585404.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+28++Filed+by%3A+Meister+Keith+A./26585404.html</guid>
   <pubDate>Mon, 01 Jun 2026 18:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>Form  4          ILLUMINA, INC.            For: May 28  Filed by: Meister Keith A.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+28++Filed+by%3A+Meister+Keith+A./26585404.html</link>
   <description>si-local-file:///var/storage/secattach/20260601/26585404.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+28++Filed+by%3A+Meister+Keith+A./26585404.html</guid>
   <pubDate>Mon, 01 Jun 2026 18:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>Form  4          ILLUMINA, INC.            For: May 29  Filed by: Davies Scott M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+29++Filed+by%3A+Davies+Scott+M/26584246.html</link>
   <description>si-local-file:///var/storage/secattach/20260601/26584246.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+29++Filed+by%3A+Davies+Scott+M/26584246.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>Form  4          ILLUMINA, INC.            For: May 29  Filed by: Davies Scott M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+29++Filed+by%3A+Davies+Scott+M/26584246.html</link>
   <description>si-local-file:///var/storage/secattach/20260601/26584246.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+29++Filed+by%3A+Davies+Scott+M/26584246.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>Form  4          ILLUMINA, INC.            For: May 28  Filed by: Ericksen Scott D</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+28++Filed+by%3A+Ericksen+Scott+D/26584128.html</link>
   <description>si-local-file:///var/storage/secattach/20260601/26584128.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+28++Filed+by%3A+Ericksen+Scott+D/26584128.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>Form  4          ILLUMINA, INC.            For: May 28  Filed by: Ericksen Scott D</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+28++Filed+by%3A+Ericksen+Scott+D/26584128.html</link>
   <description>si-local-file:///var/storage/secattach/20260601/26584128.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ILLUMINA%2C+INC.++++++++++++For%3A+May+28++Filed+by%3A+Ericksen+Scott+D/26584128.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>IDT partners with Illumina for oncology research workflows</title>
   <link>http://www.streetinsider.com/Corporate+News/IDT+partners+with+Illumina+for+oncology+research+workflows/26580146.html</link>
   <description>&lt;p&gt;Integrated DNA Technologies announced a collaboration with Illumina Inc. (NASDAQ: ILMN) to develop DRAGEN secondary analysis pipelines for IDT xGen FFPE and cfDNA next generation sequencing library preparation with custom panels.&lt;/p&gt;&lt;p&gt;The partnership creates an integrated workflow for somatic oncology research that connects IDT's library preparation with Illumina's DRAGEN secondary analysis platform. The DRAGEN Somatic for IDT Custom Panels includes a low-quality FFPE mode designed to analyze challenging samples.&lt;/p&gt;&lt;p&gt;IDT's xGen FFPE and cfDNA workflows currently support hundreds of thousands of samples annually, according to the press release. The collaboration aims to reduce analysis burden by streamlining the process from sample to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/IDT+partners+with+Illumina+for+oncology+research+workflows/26580146.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:59:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	  </item>
  <item>
   <title>Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights</title>
   <link>http://www.streetinsider.com/Press+Releases/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis

&lt;/li&gt;
&lt;li&gt;
DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection

&lt;/li&gt;
&lt;li&gt;
The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    BOULDER, Colo.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fidtb.io%2Fmy12xf&amp;amp;esheet=54544238&amp;amp;newsitemid=20260601355944&amp;amp;lan=en-US&amp;amp;anchor=Integrated+DNA+Technologies&amp;amp;index=1&amp;amp;md5=bfe2e1b911f60fc9cc3d1f6bbf4e021d&quot; shape=&quot;rect&quot;&gt;Integrated DNA Technologies&lt;/a&gt; (IDT), a Danaher company and global leader in genomics, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) to enable a DRAGEN™ secondary analysis pipeline for IDT xGen™ FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08400000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.55113337</category>
   	  </item>
  <item>
   <title>Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights</title>
   <link>http://www.streetinsider.com/Press+Releases/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis

&lt;/li&gt;
&lt;li&gt;
DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection

&lt;/li&gt;
&lt;li&gt;
The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    BOULDER, Colo.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fidtb.io%2Fmy12xf&amp;amp;esheet=54544238&amp;amp;newsitemid=20260601355944&amp;amp;lan=en-US&amp;amp;anchor=Integrated+DNA+Technologies&amp;amp;index=1&amp;amp;md5=bfe2e1b911f60fc9cc3d1f6bbf4e021d&quot; shape=&quot;rect&quot;&gt;Integrated DNA Technologies&lt;/a&gt; (IDT), a Danaher company and global leader in genomics, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) to enable a DRAGEN™ secondary analysis pipeline for IDT xGen™ FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08400000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.55113337</category>
   	  </item>
  <item>
   <title>Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights</title>
   <link>http://www.streetinsider.com/Press+Releases/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis

&lt;/li&gt;
&lt;li&gt;
DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection

&lt;/li&gt;
&lt;li&gt;
The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    BOULDER, Colo.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fidtb.io%2Fmy12xf&amp;amp;esheet=54544238&amp;amp;newsitemid=20260601355944&amp;amp;lan=en-US&amp;amp;anchor=Integrated+DNA+Technologies&amp;amp;index=1&amp;amp;md5=bfe2e1b911f60fc9cc3d1f6bbf4e021d&quot; shape=&quot;rect&quot;&gt;Integrated DNA Technologies&lt;/a&gt; (IDT), a Danaher company and global leader in genomics, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) to enable a DRAGEN™ secondary analysis pipeline for IDT xGen™ FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08400000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.55113337</category>
   	  </item>
  <item>
   <title>Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights</title>
   <link>http://www.streetinsider.com/Press+Releases/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis

&lt;/li&gt;
&lt;li&gt;
DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection

&lt;/li&gt;
&lt;li&gt;
The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    BOULDER, Colo.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fidtb.io%2Fmy12xf&amp;amp;esheet=54544238&amp;amp;newsitemid=20260601355944&amp;amp;lan=en-US&amp;amp;anchor=Integrated+DNA+Technologies&amp;amp;index=1&amp;amp;md5=bfe2e1b911f60fc9cc3d1f6bbf4e021d&quot; shape=&quot;rect&quot;&gt;Integrated DNA Technologies&lt;/a&gt; (IDT), a Danaher company and global leader in genomics, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) to enable a DRAGEN™ secondary analysis pipeline for IDT xGen™ FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08400000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.55113337</category>
   	  </item>
  <item>
   <title>Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights</title>
   <link>http://www.streetinsider.com/Press+Releases/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis

&lt;/li&gt;
&lt;li&gt;
DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection

&lt;/li&gt;
&lt;li&gt;
The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    BOULDER, Colo.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fidtb.io%2Fmy12xf&amp;amp;esheet=54544238&amp;amp;newsitemid=20260601355944&amp;amp;lan=en-US&amp;amp;anchor=Integrated+DNA+Technologies&amp;amp;index=1&amp;amp;md5=bfe2e1b911f60fc9cc3d1f6bbf4e021d&quot; shape=&quot;rect&quot;&gt;Integrated DNA Technologies&lt;/a&gt; (IDT), a Danaher company and global leader in genomics, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) to enable a DRAGEN™ secondary analysis pipeline for IDT xGen™ FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08400000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.55113337</category>
   	  </item>
  <item>
   <title>Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights</title>
   <link>http://www.streetinsider.com/Business+Wire/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis

&lt;/li&gt;
&lt;li&gt;
DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection

&lt;/li&gt;
&lt;li&gt;
The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    BOULDER, Colo.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fidtb.io%2Fmy12xf&amp;amp;esheet=54544238&amp;amp;newsitemid=20260601355944&amp;amp;lan=en-US&amp;amp;anchor=Integrated+DNA+Technologies&amp;amp;index=1&amp;amp;md5=bfe2e1b911f60fc9cc3d1f6bbf4e021d&quot; shape=&quot;rect&quot;&gt;Integrated DNA Technologies&lt;/a&gt; (IDT), a Danaher company and global leader in genomics, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) to enable a DRAGEN™ secondary analysis pipeline for IDT xGen™ FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08400000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.55113337</category>
   	  </item>
  <item>
   <title>Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights</title>
   <link>http://www.streetinsider.com/Business+Wire/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis

&lt;/li&gt;
&lt;li&gt;
DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection

&lt;/li&gt;
&lt;li&gt;
The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    BOULDER, Colo.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fidtb.io%2Fmy12xf&amp;amp;esheet=54544238&amp;amp;newsitemid=20260601355944&amp;amp;lan=en-US&amp;amp;anchor=Integrated+DNA+Technologies&amp;amp;index=1&amp;amp;md5=bfe2e1b911f60fc9cc3d1f6bbf4e021d&quot; shape=&quot;rect&quot;&gt;Integrated DNA Technologies&lt;/a&gt; (IDT), a Danaher company and global leader in genomics, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) to enable a DRAGEN™ secondary analysis pipeline for IDT xGen™ FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08400000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.55113337</category>
   	  </item>
  <item>
   <title>Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights</title>
   <link>http://www.streetinsider.com/Business+Wire/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis

&lt;/li&gt;
&lt;li&gt;
DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection

&lt;/li&gt;
&lt;li&gt;
The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    BOULDER, Colo.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fidtb.io%2Fmy12xf&amp;amp;esheet=54544238&amp;amp;newsitemid=20260601355944&amp;amp;lan=en-US&amp;amp;anchor=Integrated+DNA+Technologies&amp;amp;index=1&amp;amp;md5=bfe2e1b911f60fc9cc3d1f6bbf4e021d&quot; shape=&quot;rect&quot;&gt;Integrated DNA Technologies&lt;/a&gt; (IDT), a Danaher company and global leader in genomics, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) to enable a DRAGEN™ secondary analysis pipeline for IDT xGen™ FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08400000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.55113337</category>
   	  </item>
  <item>
   <title>Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights</title>
   <link>http://www.streetinsider.com/Business+Wire/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis

&lt;/li&gt;
&lt;li&gt;
DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection

&lt;/li&gt;
&lt;li&gt;
The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    BOULDER, Colo.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fidtb.io%2Fmy12xf&amp;amp;esheet=54544238&amp;amp;newsitemid=20260601355944&amp;amp;lan=en-US&amp;amp;anchor=Integrated+DNA+Technologies&amp;amp;index=1&amp;amp;md5=bfe2e1b911f60fc9cc3d1f6bbf4e021d&quot; shape=&quot;rect&quot;&gt;Integrated DNA Technologies&lt;/a&gt; (IDT), a Danaher company and global leader in genomics, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) to enable a DRAGEN™ secondary analysis pipeline for IDT xGen™ FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08400000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.55113337</category>
   	  </item>
  <item>
   <title>Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights</title>
   <link>http://www.streetinsider.com/Business+Wire/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis

&lt;/li&gt;
&lt;li&gt;
DRAGEN™ pipelines optimized for IDT custom hybrid capture panels enable accurate, efficient, variant detection

&lt;/li&gt;
&lt;li&gt;
The DRAGEN Somatic for IDT Custom Panels feature a new, low-quality FFPE mode to analyze challenging samples

&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    BOULDER, Colo.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fidtb.io%2Fmy12xf&amp;amp;esheet=54544238&amp;amp;newsitemid=20260601355944&amp;amp;lan=en-US&amp;amp;anchor=Integrated+DNA+Technologies&amp;amp;index=1&amp;amp;md5=bfe2e1b911f60fc9cc3d1f6bbf4e021d&quot; shape=&quot;rect&quot;&gt;Integrated DNA Technologies&lt;/a&gt; (IDT), a Danaher company and global leader in genomics, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) to enable a DRAGEN™ secondary analysis pipeline for IDT xGen™ FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Integrated+DNA+Technologies+Announces+End-to-End+Oncology+Research+Workflows+Optimized+on+Illumina+Software+for+Faster+Insights/26580136.html</guid>
   <pubDate>Mon, 01 Jun 2026 08:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08400000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.55113337</category>
   	  </item>
  <item>
   <title>Illumina (ILMN) PT Raised to $180 at Guggenheim</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Illumina+%28ILMN%29+PT+Raised+to+%24180+at+Guggenheim/26579136.html</link>
   <description>(Updated - June 1, 2026 7:20 AM EDT)

&lt;p&gt;Guggenheim analyst Subbu Nambi raised the price target on Illumina (NASDAQ: ILMN) to $180.00 (from $170.00) while maintaining a Buy rating.&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;Last week, we hosted ILMN's CFO and IR for a series of investor meetings. Our key areas of focus were 1] consumables pricing power, 2] clinical end market growth potential, 3] the bridge needed to hit LRP targets, and 4] pipeline products. We come away from our meetings firmer on ILMN's hold on the clinical sequencing market, poised for continued expansion from on-market assays and future investment, all despite the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Illumina+%28ILMN%29+PT+Raised+to+%24180+at+Guggenheim/26579136.html</guid>
   <pubDate>Mon, 01 Jun 2026 07:20:50 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	  </item>
  <item>
   <title>Illumina (ILMN) PT Raised to $180 at Guggenheim</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Illumina+%28ILMN%29+PT+Raised+to+%24180+at+Guggenheim/26579136.html</link>
   <description>(Updated - June 1, 2026 7:20 AM EDT)

&lt;p&gt;Guggenheim analyst Subbu Nambi raised the price target on Illumina (NASDAQ: ILMN) to $180.00 (from $170.00) while maintaining a Buy rating.&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;Last week, we hosted ILMN's CFO and IR for a series of investor meetings. Our key areas of focus were 1] consumables pricing power, 2] clinical end market growth potential, 3] the bridge needed to hit LRP targets, and 4] pipeline products. We come away from our meetings firmer on ILMN's hold on the clinical sequencing market, poised for continued expansion from on-market assays and future investment, all despite the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Illumina+%28ILMN%29+PT+Raised+to+%24180+at+Guggenheim/26579136.html</guid>
   <pubDate>Mon, 01 Jun 2026 07:20:50 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	  </item>
  <item>
   <title>Form  144        ILLUMINA, INC.                         Filed by: Corvex Management LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Corvex+Management+LP/26576865.html</link>
   <description>si-local-file:///var/storage/secattach/20260529/26576865.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Corvex+Management+LP/26576865.html</guid>
   <pubDate>Fri, 29 May 2026 18:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
  <item>
   <title>Form  144        ILLUMINA, INC.                         Filed by: Corvex Management LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Corvex+Management+LP/26576865.html</link>
   <description>si-local-file:///var/storage/secattach/20260529/26576865.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++ILLUMINA%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Corvex+Management+LP/26576865.html</guid>
   <pubDate>Fri, 29 May 2026 18:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00024621</category>
   	  </item>
 </channel>
</rss>
